Predictions
Innate Pharma
Start price
Target price
Perf. (%)
€4.10
15.11.20
15.11.20
€5.50
15.11.21
15.11.21
7.86%
16.11.21
16.11.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€19.59
31.10.21
31.10.21
€30.00
31.10.22
31.10.22
8.63%
13.11.21
13.11.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Virbac S.A.
Start price
Target price
Perf. (%)
€395.50
25.10.21
25.10.21
€480.00
25.10.22
25.10.22
1.52%
07.11.21
07.11.21
Could be worthwhile Investment >10% per year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€3.53
03.11.20
03.11.20
€10.50
04.11.21
04.11.21
51.47%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Bastide Le Confort
Start price
Target price
Perf. (%)
€45.70
11.10.20
11.10.20
€48.00
04.11.21
04.11.21
-7.11%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Onxeo S.A.
Start price
Target price
Perf. (%)
€0.64
11.10.20
11.10.20
€0.80
04.11.21
04.11.21
-23.46%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Nanobiotix
Start price
Target price
Perf. (%)
€8.08
29.05.20
29.05.20
€11.00
04.11.21
04.11.21
9.22%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Transgene S.A.
Start price
Target price
Perf. (%)
€1.90
04.05.20
04.05.20
€2.80
04.11.21
04.11.21
21.05%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Quantum Genomics S.A.
Start price
Target price
Perf. (%)
€2.87
09.04.20
09.04.20
€4.00
04.11.21
04.11.21
40.63%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
AB Science S.A.
Start price
Target price
Perf. (%)
€5.24
15.11.19
15.11.19
€12.00
04.11.21
04.11.21
148.86%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Abivax S.A.
Start price
Target price
Perf. (%)
€9.85
07.11.19
07.11.19
€28.00
04.11.21
04.11.21
184.77%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Virbac S.A.
Start price
Target price
Perf. (%)
€275.00
28.04.21
28.04.21
€270.00
28.04.22
28.04.22
43.82%
25.10.21
25.10.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€12.95
03.10.21
03.10.21
€20.00
03.10.22
03.10.22
15.83%
16.10.21
16.10.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€6.61
18.09.21
18.09.21
€3.00
18.09.22
18.09.22
-22.01%
02.10.21
02.10.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Inventiva SA
Start price
Target price
Perf. (%)
€3.24
10.09.21
10.09.21
€12.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€3.24
10.09.21
10.09.21
€8.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€5.10
30.07.21
30.07.21
-
30.07.22
30.07.22
2.55%
08.08.21
08.08.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€10.89
17.06.21
17.06.21
€8.00
17.06.22
17.06.22
3.21%
20.07.21
20.07.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet